Bergen Teknologioverføring AS
Records under this name other than the patents Bergen Teknologioverføring AS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Back to Bergen Teknologioverføring AS
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,659,242 | Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,512,484 | Methods for determining a prognosis for survival for a patient with breast cancer Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,166,279 | Vaccine Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,259,833 | Natural Lipids Containing Non-Oxidizable Fatty Acids Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,208,121 | Anti-Axl Antagonistic Antibodies Held by another company In force · High confidence | In force | High confidence | |
| US 10,695,403 | Use of FGF19 to Increase Muscle Fiber Size Formerly held In force · High confidence | In force | High confidence | |
| US 10,920,256 | Process Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,732,048 | Anti-axl antagonistic antibodies Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,735,064 | Methods for creating and identifying functional RNA interference elements Formerly held Lapsed on the fee record Ended May 27, 2026 · USPTO record | Lapsed on the fee record | Ended May 27, 2026 | USPTO record |
| US 8,716,488 | Olefin metathesis catalysts Lapsed on the fee record Ended May 6, 2026 · USPTO record | Lapsed on the fee record | Ended May 6, 2026 | USPTO record |